| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Halpern John D is a 10% Owner at Ernexa Therapeutics Inc.. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $3.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2022 | ERNA Ernexa Therapeutics Inc. | 10% Owner | Buy | 335,920 | $3.28 | $1,101,817.60 | +292.0% | +13.6% | -63.0% |